These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29870636)

  • 21. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.
    Prats-Sánchez L; Camps-Renom P; Sotoca-Fernández J; Delgado-Mederos R; Martínez-Domeño A; Marín R; Almendrote M; Dorado L; Gomis M; Codas J; Llull L; Gómez González A; Roquer J; Purroy F; Gómez-Choco M; Cánovas D; Cocho D; Garces M; Abilleira S; Martí-Fàbregas J;
    Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials.
    Lorenz MW; Lauer A; Foerch C
    Stroke; 2015 Nov; 46(11):3168-76. PubMed ID: 26443833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS
    Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke.
    Bugnicourt JM; Duru C; Picard C; Godefroy O
    Clin Ther; 2008 Sep; 30(9):1675-80. PubMed ID: 18840373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.
    Wardlaw JM; von Kummer R; Carpenter T; Parsons M; Lindley RI; Cohen G; Murray V; Kobayashi A; Peeters A; Chappell F; Sandercock PA
    Int J Stroke; 2015 Aug; 10(6):956-68. PubMed ID: 23336348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke.
    Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ
    J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
    Kent DM; Ruthazer R; Selker HP
    Stroke; 2003 Feb; 34(2):464-7. PubMed ID: 12574561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography perfusion-based thrombolysis in wake-up stroke.
    Morelli N; Rota E; Immovilli P; Cosottini M; Giorgi-Pierfranceschi M; Magnacavallo A; Michieletti E; Morelli J; Guidetti D
    Intern Emerg Med; 2015 Dec; 10(8):977-84. PubMed ID: 26370239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous rtPA thrombolysis in acute ischemic stroke.
    Laloux P
    Acta Neurol Belg; 2001 Jun; 101(2):88-95. PubMed ID: 11486563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
    Mazya MV; Ahmed N; Ford GA; Hobohm C; Mikulik R; Nunes AP; Wahlgren N;
    Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
    Medlin F; Amiguet M; Vanacker P; Michel P
    Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous thrombolysis for ischemic stroke: Experience in 54 patients].
    Guevara O C; Bulatova K; Aravena F; Caba S; Monsalve J; Lara H; Nieto E; Navarrete I; Morales M
    Rev Med Chil; 2016 Apr; 144(4):434-41. PubMed ID: 27401375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
    Hill MD; Rowley HA; Adler F; Eliasziw M; Furlan A; Higashida RT; Wechsler LR; Roberts HC; Dillon WP; Fischbein NJ; Firszt CM; Schulz GA; Buchan AM;
    Stroke; 2003 Aug; 34(8):1925-31. PubMed ID: 12843342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor.
    Huang P; Chen CH; Yang YH; Lin RT; Lin FC; Liu CK
    Cerebrovasc Dis; 2006; 22(5-6):423-8. PubMed ID: 16912476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.